Task: Answer the multiple-choice question.
Question: Which drug has a -17.975% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a CCC(C)(C)NC(=O)c1cc(C(=O)OC)cc([N+](=O)[O-])c1
b CCOc1ccc(N2C(=O)C3C4C=CC([C@H]5CC45)[C@@H]3C2=O)cc1
Answer: a. CCC(C)(C)NC(=O)c1cc(C(=O)OC)cc([N+](=O)[O-])c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(C)(C)NC(=O)c1cc(C(=O)OC)cc([N+](=O)[O-])c1
CCC(C)(C)NC(=O)c1cc(C(=O)OC)cc([N+](=O)[O-])c1
methyl 3-(2-methylbutan-2-ylcarbamoyl)-5-nitrobenzoate